Home › Cancro dell'endometrio › Virginia › Charlottesville
Studi clinici su Cancro dell'endometrio a Charlottesville, VA
13 studi su Cancro dell'endometrio cercano partecipanti presso sedi a Charlottesville e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- University of Virginia Cancer Center, Charlottesville
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
In reclutamentoFase 3
- University of Virginia Cancer Center, Charlottesville
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
In reclutamentoFase 1
- University of Virginia, Charlottesville
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
In reclutamentoFase 2
- University of Virginia Cancer Center, Charlottesville
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
In reclutamentoFase 2
- University of Virginia Cancer Center, Charlottesville
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
In reclutamentoFase 3
- University of Virginia, Charlottesville
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
In reclutamentoFase 3
- Research Site, Charlottesville
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
In reclutamentoFase 1
- University of Virginia, Charlottesville
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
In reclutamentoFase 2
- University of Virginia Health System, Charlottesville
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
In reclutamentoFase 1/2
- University of Virginia Health System, Charlottesville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- University of Virginia, Charlottesville
Vaginal Cuff Brachytherapy Fractionation Study
In reclutamentoFase 3
- University of Virginia, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Charlottesville
Studi su Cancro dell'endometrio in altre città
- Houston, TX68 studi
- New York City, NY52 studi
- Boston, MA50 studi
- Arlington, VA39 studi
- Nashville, TN38 studi
- Los Angeles, CA34 studi
- St. Louis, MO29 studi
- Philadelphia, PA28 studi
- San Antonio, TX27 studi
- Chicago, IL25 studi
- Columbus, OH25 studi
- Queens, NY25 studi
Altri studi a Charlottesville
- Cancro del polmone non a piccole cellule21 studi
- Leucemia mieloide acuta16 studi
- Cancro alla prostata15 studi
- Cancro metastatico13 studi
- Cancro (tutti i tipi)13 studi
- Cancro ai polmoni13 studi
- Insufficienza cardiaca11 studi
- Cancro ovarico10 studi
- Cancro colorettale10 studi
- Diabete di tipo 19 studi
- Cancro al seno9 studi
- Cancro pancreatico9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.